On Cancer

Filter by Tag

Perspective

Making Clinical Trials More Efficient, Informative, and Effective

By Paul Sabbatini, MD, Deputy Physician-in-Chief for Clinical Research | Friday, July 26, 2013

The clinical trial remains our best tool to identify new therapies, but as with all tools, innovation is required if trials are to remain relevant.

Tags: Cancer Care; Research; Clinical Trials; Personalized Medicine; Drug Discovery

In the News

Memorial Sloan-Kettering’s Collaboration with IBM Watson Featured on CBS This Morning

By Media Staff | Tuesday, July 9, 2013

Medical oncologist Mark G. Kris and one of his patients were interviewed for a CBS This Morning segment that describes how a Memorial Sloan-Kettering team trains the supercomputer IBM Watson to help doctors identify the best cancer management options for individual patients.

Tags: Cancer Care; Personalized Medicine; Medical Technology; Treatment

In the Lab

Investigators Sequence the Genome of a Rare Head and Neck Cancer

By Julie Grisham, MS, Science Writer/Editor | Friday, May 24, 2013

Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan-Kettering.

Tags: Cancer Biology; Cancer Care; Lab Research; Research; Cancer Genetics; Computational Biology; Personalized Medicine; Head & Neck Cancers

Q&A

Increased Emphasis on Clinical Research to Advance Cancer Treatment

By Media Staff | Tuesday, April 2, 2013

In his new role as Deputy Physician-in-Chief for Clinical Research, Paul Sabbatini aims to streamline, accelerate, and expand Memorial Sloan-Kettering’s clinical research program.

Tags: Cancer Care; Research; Clinical Trials; Personalized Medicine

Perspective

Memorial Sloan-Kettering's Mark Kris on Partnership with IBM Watson

By Mark Kris, MD, Chief, Thoracic Oncology Service | Friday, February 8, 2013

Medical oncologist Mark Kris discusses how cancer experts are working to train IBM Watson to help assist medical professionals.

Tags: Cancer Care; Research; Personalized Medicine; Medical Technology; Breast Cancer; Treatment; Lung Cancer

In the Clinic

Blood Test Could Predict Which Patients with Pancreatic Cancer May Benefit from Chemotherapy

By Media Staff | Tuesday, January 29, 2013

New research suggests that analyzing genetic changes found in the bloodstream may help doctors predict which chemotherapy regimens will work for some patients.

Tags: Cancer Care; Research; Clinical Research; Chemotherapy; Personalized Medicine; Treatment; Pancreatic Cancer

In the Clinic

Projects Led by Memorial Sloan-Kettering Investigators Listed among Top Cancer Advances of 2012

By Media Staff | Monday, January 7, 2013

The American Society of Clinical Oncology’s notable research advances include the approval of a new drug for men with advanced prostate cancer that was developed and studied by Memorial Sloan-Kettering researchers.

Tags: Cancer Care; Research; Clinical Trials; Personalized Medicine; Targeted Therapy; Screening; Treatment

In the Lab

Genome Sequencing of One Patient’s Tumor Could Lead to New Treatment Options for Some Bladder Cancer Patients

By Eva Kiesler, PhD, Science Writer/Editor | Monday, September 17, 2012

When new cancer drugs are shown to be largely ineffective, exceptional cases of good outcome may pave the way for new treatments that could benefit a smaller group of patients.

Tags: Cancer Biology; Cancer Care; Lab Research; Research; Cancer Genetics; Personalized Medicine; Bladder Cancer; Targeted Therapy

Finding

Testing for Mutations Identified in Squamous Cell Lung Cancer Tumors Helps Personalize Treatment

By Media Staff | Thursday, May 17, 2012

Memorial Sloan-Kettering was one of the first centers to use this type of genetic testing for lung cancer patients and is currently one of the only centers testing for mutations in squamous cell carcinomas of the lung.

Tags: Cancer Care; Lab Research; Research; Cancer Genetics; Personalized Medicine; Lung Cancer

Pictured: American Association of Cancer Research Annual Meeting 2012

Announcement

Memorial Sloan-Kettering Discoveries in Personalized Medicine Highlighted at Major Cancer Research Meeting; Investigators Honored

By Media Staff | Tuesday, April 3, 2012

The American Association for Cancer Research (AACR), the world’s oldest and largest professional organization dedicated to advancing cancer research, held its 2012 annual meeting in Chicago.

Tags: Cancer Care; Research; Personalized Medicine; Brain Tumors; Chronic Myelogenous Leukemia; Prostate Cancer

In the Lab

Genetic Profiling Could Help Doctors Make More-Accurate Leukemia Prognoses

By Jim Stallard, MA, Writer/Editor | Thursday, March 15, 2012

Researchers have identified a set of genetic abnormalities that can enhance prognostic accuracy and aid treatment selection for people with acute myelogenous leukemia (AML).

Tags: Cancer Biology; Lab Research; Research; Acute Myelogenous Leukemia; Cancer Genetics; Pediatric Leukemias; Personalized Medicine; Leukemias

In the News

Memorial Sloan-Kettering Made Major Contributions to Cancer Advances in 2011

By Julie Grisham, MS, Science Writer/Editor | Monday, February 6, 2012

Two of the year’s top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan-Kettering investigators.

Tags: Cancer Care; Research; Personalized Medicine; Targeted Therapy; Melanoma; Ovarian Cancer; Prostate Cancer

In the Lab

Genetic Study Identifies Mutations in Pediatric Cancers

By Jim Stallard, MA, Writer/Editor | Wednesday, February 1, 2012

Memorial Sloan-Kettering researchers have performed the first large-scale genetic analysis of several pediatric cancers, identifying mutations and potential targets for therapies to treat the cancers.

Tags: Cancer Biology; Ewing Sarcoma; Lab Research; Research; Neuroblastoma; Cancer Genetics; Pediatric Cancer Care; Personalized Medicine; Rhabdomyosarcoma

Prediction Tool

New Online Tool Helps Predict Outcomes after Ovarian Cancer

By Memorial Sloan-Kettering | Wednesday, January 25, 2012

Our ovarian cancer nomogram is a personalized tool that can help you and your doctor make important treatment decisions after surgery.

Tags: Cancer Care; Personalized Medicine; Ovarian Cancer

In the News

CBS Evening News: Therapy to Target Each Patient's Unique Cancer

By Media Staff | Wednesday, November 23, 2011

Chief of Thoracic Oncology Mark Kris offers his perspective on a promising new tactic for treating lung and other cancers in this story from CBS Evening News with Scott Pelley. The strategy tailors cancer treatment to each individual patient.

Tags: Cancer Care; Personalized Medicine; Breast Cancer; Lung Cancer